Brussels (ots/PRNewswire) - Event coincides with the publication in The Lancet Infectious Diseases of EUCLID - the largest epidemiology study on Clostridium difficile infection[1] CDI Europe, the European Hospital and Healthcare Federation (HOPE) and MEP Karin Kadenbach today hosted an event at the European ...
Stockholm (ots/PRNewswire) - A customized version of SyntheticMR AB's SyMRI(R) IMAGE software is now introduced by GE Healthcare, a strategic partner to SyntheticMR, under the name MAGiC. MAGiC is introduced at RSNA together with the new magnetic resonance (MR) system SIGNA Pioneer from GE Healthcare. MAGiC (Magnetic Resonance Image Compilation) is a customized version of SyntheticMR's SyMRI IMAGE software, a breakthrough ...
Munich (ots/PRNewswire) - - Survey findings show that 97% of European cardiologists believe that non-valvular atrial fibrillation (NVAF) patients experience a delay in diagnosis,[1] which is associated with a higher risk of stroke[2] - European Cardiologists reveal the importance of reviewing patient ...
Mumbai, India (ots/PRNewswire) - Cipla Europe NV ("Cipla"), a global pharmaceutical company is delighted to announce that it has signed a distribution agreement with Serum Institute of India Ltd. (SII) - a global leader in the production of vaccines. Under the agreement, SII will develop and manufacture paediatric ...
Lyon, France (ots/PRNewswire) - Clostridium difficile infection,a potentially fatal disease,[2]is at leasttwice as common as MRSA infections in hospitals[3],[4]and is estimated to cost the EU EUR3 billion per annum[5] A first of its kind expert consensus report on Clostridium difficile infection (CDI), contributed ...
Bagsværd, Denmark (ots/PRNewswire) - Today, on World Diabetes Day, the Chinese cities of Tianjin and Shanghai join the Cities Changing Diabetes initiative and the global fight against the urban diabetes epidemic. These two major metropolitan centres are the first Chinese cites to become part of the global partnership programme, which was initiated in Mexico City in ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - The Partnering for Cure faculty of experts today announced the four recipients of awards for research proposals that will help to provide insights into the pathophysiology of viral diseases and the potential development of cure strategies in HIV, hepatitis B (HBV) and hepatitis C (HCV). As ...
European Society for Medical Oncology (ESMO)
Lugano, Switzerland (ots) - The European Society for Medical Oncology, the pan-European association representing medical oncologists in Europe and beyond, has announced that it will be organising an annual Congress in Europe from 2016. A record 19,809 participants from 134 countries gathered at ESMO 2014 in Madrid to hear the results of trials which included ...
New York (ots/PRNewswire) - - PAHO (Pan American Health Organization) Foundation and International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) combine efforts to improve breast and cervical cancer prevention and control. - The partnership aims to improve understanding and practices among ...
Uithoorn, The Netherlands (ots/PRNewswire) - HOYA will be headline sponsor at the European Academy of Optometry and Optics' (EAOO) annual conference in Budapest 2015. HOYA will also sponsor the clinical skills workshops at the Budapest conference which will be held from 14-17 May 2015. The conference is a joint meeting with the European Council of Optometry and Optics (ECOO), in association with the Hungarian Craft Union ...
London (ots/PRNewswire) - More than 170 international policymakers, senior business leaders, academics, and patient advocates, are convening in London on November 25th to discuss the urgent need for a global response to the increasing impact of depression. The Conference entitled 'The Global Crisis of Depression - ...
Asklepios Kliniken GmbH & Co. KGaA
Hamburg (ots) - - Cross reference: Additional information available at http://ots.de/taeAX - Copper has been shown to have antimicrobial properties and significantly reduce dangerous germs such as bacteria, fungi and viruses. Door handles are the most commonly used contact surfaces in hospitals. A recent on-site ...
London (ots/PRNewswire) - Loss of the ability to self-care and live independently are the most feared social-related outcomes of a stroke,[a] a survey of seven European countries reveals today on World Stroke Day. Yet only one in a hundred respondents surveyed were able to correctly identify all four main ways to ...
London (ots/PRNewswire) ...
Buffalo Grove, Illinois (ots/PRNewswire) - Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has entered into a definitive agreement to acquire Devicor Medical Products, Inc. Devicor is a global market leader in breast biopsy instruments and consumables, with annual revenues of approximately $170 million. Devicor, headquartered in Cincinnati, Ohio, has ...
London (ots/PRNewswire) - New report from Globe Life Sciences finds that combination therapy may be the key that finally allows cancer vaccines to fulfil their potential Globe Life Sciences, a leading provider of commercial analysis within healthcare-related sectors, conducted a detailed review of 17 late-stage cancer vaccines. The Globe Extraordinary report, entitled 'Future of Cancer Vaccines - An Analysis of Late-stage ...
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc.
Berlin (ots/PRNewswire) - Takeda Pharmaceuticals International GmbH ("Takeda") and Sunovion Pharmaceuticals Inc. ("Sunovion") presented new evidence supporting the use of Latuda(R) (lurasidone), an atypical antipsychotic treatment for adults with schizophrenia, during multiple poster sessions at the 27th European ...
The International Osteoporosis Foundation (IOF)
Nyon, Switzerland (ots) - Osteoporosis can lead to painful fractures, disability and early death, but continues to be ignored by the general public and neglected by doctors during routine physical check-ups New survey findings released on World Osteoporosis Day by the International Osteoporosis Foundation (IOF), show that on average, 90% of 13,258 adults questioned are unaware of how common osteoporotic fractures are in ...
JTI Japan Tobacco International AG
Geneva (ots/PRNewswire) - "An Alarming Attempt to Erode Countries' Sovereignty on Taxation Policies" Yesterday at the WHO FCTC's Conference of the Parties (COP6) in Moscow, guidelines on price and tax measures (Article 6) were hurriedly adopted behind closed doors, further demonstrating the FCTC's habit of infringing on issues of national sovereignty. (Logo: ...
Lausanne, Switzerland (ots/PRNewswire) - - Galderma, in partnership with the International League of Dermatological Societies, has launched the search for initiatives that will fulfil an important role in strengthening the global dermatology community - The SKINPACT Awards, part of a wider programme with social ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced that the United Stated Patent and Trademark Office (USPTO) has published ...
Montreal (ots/PRNewswire) - Updated clinical trial data from REPLICor's three Asian trials using its nucleic acid polymer (NAP) HBsAg-release inhibitors REP 2055 (REP 9AC) and REP 2139 (REP 9AC') will be presented at the 10th Annual Meeting of the Oligonucleotide Society, to be held from Oct 12-16, 2014 in San ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced that the United Stated Patent and Trademark Office (USPTO) has published ...
Darmstadt, Germany (ots/PRNewswire) - - Global winners selected for their unique research projects that have the potential to advance research for the personalized treatment of solid tumors - Winners chosen by a Scientific Steering Committee comprising internationally renowned oncologists and researchers Merck Serono, the biopharmaceutical division of Merck, today ...
Ingelheim, Germany (ots/PRNewswire) - - Results from the LUX-Head & Neck 1 study show afatinib* significantly delayed tumour growth versus chemotherapy in patients following failure of their previous treatment, reducing the risk for disease progression by 20% - Head and neck cancer has a very poor prognosis with no ...
Chertsey, England (ots/PRNewswire) - $150,000 Grant will be awarded on Saturday 27th September The Astellas European Foundation has announced the shortlist for the 2014 Uro-Oncology Grant. The Grant programme supports basic medical and related scientific programmes which contribute to advancements in urological oncology. The five finalists include applications from The ...
Aachen (ots) - EMBARGO: This information is for European healthcare professionals only. Not intended for UK audience. Low back pain is one of the most common chronic pain conditions. Studies have shown that up to 85% of people worldwide will suffer from back pain during their lives.(1) A high percentage of severe ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for US- and UK-based media ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT: 996P; Pipeline: pimasertib: 443O; c-Met: 1333TiP, 450PD, 744TiP, 745TiP; further pipeline: 772P, 507PD, 1235P - New research ...
Darmstadt, Germany (ots/PRNewswire) - - The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting - Investment supports innovative projects for the advancement of science and medical research in the field of growth Merck Serono, the biopharmaceutical division of Merck, today announced the first recipients of the ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media Merck announced today that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage ...